135 related articles for article (PubMed ID: 18057721)
1. In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes.
Nonaka R; Nagai F; Ogata A; Satoh K
Biol Pharm Bull; 2007 Dec; 30(12):2328-33. PubMed ID: 18057721
[TBL] [Abstract][Full Text] [Related]
2. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
Nagai F; Nonaka R; Satoh Hisashi Kamimura K
Eur J Pharmacol; 2007 Mar; 559(2-3):132-7. PubMed ID: 17223101
[TBL] [Abstract][Full Text] [Related]
3. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
Odagaki Y; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386
[TBL] [Abstract][Full Text] [Related]
4. [In-vitro screening of psychoactive drugs to prevent abuses].
Satoh K; Nonaka R
Yakugaku Zasshi; 2008 Dec; 128(12):1771-82. PubMed ID: 19043296
[TBL] [Abstract][Full Text] [Related]
5. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 5-HT(1B/1D) agonist-stimulated [(35)S]GTPgammaS binding in rat and guinea pig striatal membranes.
Mize AL; Alper RH
Brain Res; 1999 Jul; 836(1-2):229-36. PubMed ID: 10415426
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
Odagaki Y; Toyoshima R
Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
9. Abuse liability profile of three substituted tryptamines.
Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
[TBL] [Abstract][Full Text] [Related]
10. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
Odagaki Y; Kinoshita M; Toyoshima R
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of alpha2D-adrenergic receptor-mediated [35S]GTPgammaS binding in rat cerebral cortical membranes.
Odagaki Y; Toyoshima R
Pharmacol Res; 2008 Jun; 57(6):435-44. PubMed ID: 18515144
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
[TBL] [Abstract][Full Text] [Related]
14. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
15. Autoradiography of serotonin 5-HT1A receptor-activated G proteins in guinea pig brain sections by agonist-stimulated [35S]GTPgammaS binding.
Dupuis DS; Palmier C; Colpaert FC; Pauwels PJ
J Neurochem; 1998 Mar; 70(3):1258-68. PubMed ID: 9489749
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.
Cozzi NV; Daley PF
Bioorg Med Chem Lett; 2016 Feb; 26(3):959-964. PubMed ID: 26739781
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
[TBL] [Abstract][Full Text] [Related]
18. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
Vorce SP; Sklerov JH
J Anal Toxicol; 2004 Sep; 28(6):407-10. PubMed ID: 15516287
[TBL] [Abstract][Full Text] [Related]
19. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ
Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431
[TBL] [Abstract][Full Text] [Related]
20. Functional coupling between adenosine A
Odagaki Y; Kinoshita M; Ota T; Meana JJ; Callado LF; Matsuoka I; García-Sevilla JA
Purinergic Signal; 2018 Jun; 14(2):177-190. PubMed ID: 29492786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]